BioMarin Pharma (BMRN) Misses Q4 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. JNJ
2. META
3. OIG
4. NRIX
5. SNDX
6. HUM
7. S
8. ENTX
9. STM
10. JPM

Go back to BioMarin Pharma (BMRN) Misses Q4 EPS by 7c

BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $127 at JPMorgan

February 23, 2018 7:27 AM EST

JPMorgan lowered its price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $127.00 (from $129.00) while maintaining a Overweight rating.

... More

BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $100 at Citi Following 4Q

February 23, 2018 7:11 AM EST

Citi raised its price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $100.00 (from $96.00) while maintaining a Buy rating following the company's 4Q. Results were in-line with consensus estimates on the top-line, while the bottom-line was a miss due to tax impact.

The company... More